Anthem Biosciences Share Price
854.45+18.95 (+2.27%)
+21.53% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
ANTHEMNSE
Anthem Biosciences Share Price
854.45+18.95 (+2.27%)
+21.53% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| 32% | 14% | 26% | 15% |
| 43% | 17% | 15% | 31% |
| - | - | - | 22% |
| 33% | 25% | 21% | 22% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
LAURUSLABS
ZYDUSLIFE
DRREDDY
CIPLA
MANKIND
AUROPHARMA
LUPIN
ANTHEM
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,769.9 | ₹424202 Cr | 38.68 | 8.29 | 58.23 | ₹11479 Cr |
| 10,064 | ₹264141 Cr | 90.3 | 34.04 | 128.41 | ₹2568 Cr |
| 4,650 | ₹174402 Cr | 82.11 | 14.04 | 106.21 | ₹2163 Cr |
| 2,323 | ₹126811 Cr | 94.64 | 8.17 | 33.94 | ₹889 Cr |
| 1,240.6 | ₹123685 Cr | 27.41 | 9.42 | 62.53 | ₹5040 Cr |
| 1,368.3 | ₹111868 Cr | 39.95 | 11.08 | 59.2 | ₹4196 Cr |
| 1,396.9 | ₹111650 Cr | 38.54 | 10.86 | 52.6 | ₹3879 Cr |
| 2,475 | ₹102196 Cr | 45.57 | 17.23 | 76.26 | ₹1913 Cr |
| 1,694.5 | ₹96951 Cr | 26.11 | 17.95 | 96.84 | ₹3505 Cr |
| 2,015.9 | ₹91301 Cr | 16.51 | 30.95 | 154.35 | ₹5333 Cr |
| 854.45 | ₹47367 Cr | 82.24 | 2.13 | 12.66 | ₹592 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|
| ₹594 Cr | ₹418 Cr | ₹611 Cr | ₹423 Cr | ₹551 Cr | ₹540 Cr | ₹483 Cr | ₹498 Cr | ₹525 Cr | ₹339 Cr |
| ₹59 Cr | ₹25 Cr | ₹51 Cr | ₹34 Cr | ₹48 Cr | ₹23 Cr | ₹14 Cr | ₹24 Cr | ₹28 Cr | ₹19 Cr |
| ₹653 Cr | ₹443 Cr | ₹662 Cr | ₹457 Cr | ₹598 Cr | ₹563 Cr | ₹497 Cr | ₹522 Cr | ₹553 Cr | ₹358 Cr |
| ₹353 Cr | ₹298 Cr | ₹383 Cr | ₹300 Cr | ₹366 Cr | ₹375 Cr | ₹318 Cr | ₹359 Cr | ₹350 Cr | ₹236 Cr |
| ₹330 Cr | ₹175 Cr | ₹318 Cr | ₹191 Cr | ₹266 Cr | ₹214 Cr | ₹209 Cr | ₹184 Cr | ₹223 Cr | ₹140 Cr |
| ₹3 Cr | ₹89 L | ₹2 Cr | ₹35 L | ₹3 Cr | ₹2 Cr | ₹52 L | ₹3 Cr | ₹4 Cr | ₹4 Cr |
| ₹296 Cr | ₹145 Cr | ₹278 Cr | ₹130 Cr | ₹230 Cr | ₹186 Cr | ₹178 Cr | ₹161 Cr | ₹200 Cr | ₹118 Cr |
| ₹211 Cr | ₹120 Cr | ₹190 Cr | ₹93 Cr | ₹173 Cr | ₹136 Cr | ₹83 Cr | ₹124 Cr | ₹162 Cr | ₹82 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Trade Payables
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — | — |
| ₹112 Cr | ₹112 Cr | ₹112 Cr | ₹114 Cr | ₹9 Cr | ₹8 Cr | ₹8 Cr | ₹11 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹8 Cr |
| ₹33 Cr | ₹34 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹2897 Cr | ₹2264 Cr | ₹1813 Cr | ₹1627 Cr | ₹1346 Cr | ₹693 Cr | ₹413 Cr | ₹213 Cr | ₹138 Cr | ₹89 Cr | ₹50 Cr | ₹30 Cr |
| ₹2897 Cr | ₹2264 Cr | ₹1813 Cr | ₹1627 Cr | ₹1346 Cr | ₹693 Cr | ₹413 Cr | ₹213 Cr | ₹138 Cr | ₹89 Cr | ₹50 Cr | ₹30 Cr |
| ₹3043 Cr | ₹2410 Cr | ₹1925 Cr | ₹1741 Cr | ₹1355 Cr | ₹701 Cr | ₹422 Cr | ₹223 Cr | ₹151 Cr | ₹102 Cr | ₹64 Cr | ₹38 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹11 L | ₹8 L | ₹4 L | ₹0 |
| ₹28 Cr | ₹47 Cr | ₹112 Cr | ₹96 Cr | ₹6 Cr | ₹20 Cr | ₹76 Cr | ₹124 Cr | ₹55 Cr | ₹20 Cr | ₹14 Cr | ₹14 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹20 Cr | ₹32 Cr | ₹28 Cr | ₹30 Cr | ₹32 Cr | ₹5 Cr |
| -₹27 Cr | -₹18 Cr | -₹41 Cr | -₹25 Cr | -₹16 Cr | -₹14 Cr | -₹12 Cr | ₹5 L | -₹79 L | ₹1 Cr | ₹73 L | -₹89 L |
| ₹17 Cr | ₹17 Cr | ₹17 Cr | ₹8 Cr | ₹27 Cr | ₹20 Cr | ₹16 Cr | ₹0 | ₹54 L | ₹1 Cr | ₹44 L | ₹87 L |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹37 L | ₹50 L | ₹32 L |
| ₹16 Cr | ₹8 Cr | ₹7 Cr | ₹5 Cr | ₹5 Cr | ₹7 Cr | ₹7 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹1 Cr | ₹94 L |
| ₹34 Cr | ₹54 Cr | ₹93 Cr | ₹85 Cr | ₹22 Cr | ₹34 Cr | ₹107 Cr | ₹160 Cr | ₹86 Cr | ₹57 Cr | ₹49 Cr | ₹21 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — |
| ₹75 Cr | ₹110 Cr | ₹101 Cr | ₹72 Cr | ₹65 Cr | ₹77 Cr | ₹58 Cr | ₹33 Cr | ₹26 Cr | ₹24 Cr | ₹29 Cr | ₹13 Cr |
| ₹188 Cr | ₹146 Cr | ₹107 Cr | ₹54 Cr | ₹109 Cr | ₹102 Cr | ₹162 Cr | ₹53 Cr | ₹29 Cr | ₹12 Cr | ₹7 Cr | ₹6 Cr |
| ₹4 Cr | ₹43 Cr | ₹121 Cr | ₹29 Cr | ₹30 Cr | ₹80 Cr | ₹26 Cr | ₹35 Cr | ₹37 Cr | ₹27 Cr | ₹29 Cr | ₹21 Cr |
| ₹262 Cr | ₹186 Cr | ₹130 Cr | ₹124 Cr | ₹145 Cr | ₹97 Cr | ₹1 Cr | ₹5 Cr | ₹27 Cr | ₹13 Cr | ₹4 Cr | ₹3 Cr |
| ₹530 Cr | ₹485 Cr | ₹459 Cr | ₹279 Cr | ₹349 Cr | ₹356 Cr | ₹247 Cr | ₹126 Cr | ₹119 Cr | ₹76 Cr | ₹69 Cr | ₹43 Cr |
| ₹3606 Cr | ₹2949 Cr | ₹2477 Cr | ₹2105 Cr | ₹1726 Cr | ₹1091 Cr | ₹776 Cr | ₹510 Cr | ₹355 Cr | ₹235 Cr | ₹181 Cr | ₹102 Cr |
| ₹90 Cr | ₹54 Cr | ₹250 Cr | ₹226 Cr | ₹6 Cr | ₹11 Cr | ₹8 Cr | ₹0 | ₹0 | ₹0 | ₹9 Cr | ₹6 Cr |
| ₹51 Cr | ₹109 Cr | ₹233 Cr | ₹125 Cr | ₹35 Cr | ₹100 Cr | ₹159 Cr | ₹191 Cr | ₹119 Cr | ₹77 Cr | ₹74 Cr | ₹40 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — |
| ₹1507 Cr | ₹1300 Cr | ₹996 Cr | ₹884 Cr | ₹703 Cr | ₹682 Cr | ₹567 Cr | ₹346 Cr | ₹153 Cr | ₹136 Cr | ₹123 Cr | ₹64 Cr |
| ₹723 Cr | ₹595 Cr | ₹514 Cr | ₹435 Cr | ₹374 Cr | ₹321 Cr | ₹261 Cr | ₹88 Cr | ₹67 Cr | ₹45 Cr | ₹35 Cr | ₹27 Cr |
| ₹783 Cr | ₹705 Cr | ₹483 Cr | ₹449 Cr | ₹329 Cr | ₹361 Cr | ₹306 Cr | ₹258 Cr | ₹86 Cr | ₹91 Cr | ₹87 Cr | ₹37 Cr |
| ₹264 Cr | ₹297 Cr | ₹345 Cr | ₹164 Cr | ₹154 Cr | ₹19 Cr | ₹50 Cr | ₹43 Cr | ₹74 Cr | ₹22 Cr | ₹6 Cr | ₹17 Cr |
| ₹342 Cr | ₹121 Cr | ₹13 Cr | ₹6 Cr | ₹4 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹342 Cr | ₹121 Cr | ₹13 Cr | ₹6 Cr | ₹4 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹50 Cr | ₹29 Cr | ₹35 Cr | ₹47 Cr | ₹22 Cr | ₹24 Cr | ₹17 Cr | ₹8 Cr | ₹13 Cr | ₹12 Cr | ₹9 Cr | ₹4 Cr |
| ₹159 Cr | ₹150 Cr | ₹81 L | ₹59 L | ₹79 L | ₹27 L | ₹40 L | ₹5 Cr | ₹2 Cr | ₹3 Cr | ₹13 L | ₹9 L |
| ₹1599 Cr | ₹1301 Cr | ₹875 Cr | ₹666 Cr | ₹510 Cr | ₹404 Cr | ₹373 Cr | ₹316 Cr | ₹176 Cr | ₹128 Cr | ₹102 Cr | ₹58 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — |
| ₹666 Cr | ₹312 Cr | ₹459 Cr | ₹493 Cr | ₹269 Cr | ₹209 Cr | ₹99 Cr | ₹27 Cr | ₹8 Cr | ₹2 Cr | ₹5 Cr | ₹0 |
| ₹125 Cr | ₹340 Cr | ₹211 Cr | ₹129 Cr | ₹58 Cr | ₹35 Cr | ₹125 Cr | ₹58 Cr | ₹47 Cr | ₹37 Cr | ₹31 Cr | ₹15 Cr |
| ₹591 Cr | ₹450 Cr | ₹490 Cr | ₹274 Cr | ₹326 Cr | ₹255 Cr | ₹105 Cr | ₹74 Cr | ₹84 Cr | ₹57 Cr | ₹31 Cr | ₹10 Cr |
| ₹275 Cr | ₹172 Cr | ₹184 Cr | ₹343 Cr | ₹349 Cr | ₹41 Cr | ₹22 Cr | ₹11 Cr | ₹4 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr |
| ₹7 Cr | ₹10 Cr | ₹3 Cr | ₹3 Cr | ₹10 Cr | ₹4 Cr | ₹5 Cr | ₹11 Cr | ₹8 Cr | ₹6 Cr | ₹86 L | ₹34 L |
| ₹344 Cr | ₹362 Cr | ₹253 Cr | ₹196 Cr | ₹204 Cr | ₹143 Cr | ₹46 Cr | ₹13 Cr | ₹29 Cr | ₹4 Cr | ₹8 Cr | ₹16 Cr |
| ₹2007 Cr | ₹1647 Cr | ₹1602 Cr | ₹1438 Cr | ₹1216 Cr | ₹687 Cr | ₹403 Cr | ₹194 Cr | ₹179 Cr | ₹107 Cr | ₹79 Cr | ₹43 Cr |
| ₹1477 Cr | ₹1162 Cr | ₹1143 Cr | ₹1159 Cr | ₹867 Cr | ₹331 Cr | ₹156 Cr | ₹68 Cr | ₹61 Cr | ₹31 Cr | ₹10 Cr | -₹20 L |
| ₹3606 Cr | ₹2949 Cr | ₹2477 Cr | ₹2105 Cr | ₹1726 Cr | ₹1091 Cr | ₹776 Cr | ₹510 Cr | ₹355 Cr | ₹235 Cr | ₹181 Cr | ₹102 Cr |
| ₹54 | ₹42 | ₹34 | ₹31 | ₹1,544 | ₹827 | ₹503 | ₹264 | ₹174 | ₹116 | ₹70 | ₹50 |
| ₹54 | ₹42 | ₹34 | ₹31 | ₹24 | ₹13 | ₹8 | ₹4 | ₹3 | ₹2 | ₹1 | ₹1 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹824 Cr | ₹657 Cr | ₹477 Cr | ₹497 Cr | ₹546 Cr | ₹366 Cr | ₹121 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹85 Cr | ₹73 Cr | ₹45 Cr | ₹27 Cr | ₹49 Cr | ₹77 Cr | ₹76 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹139 Cr | -₹301 Cr | -₹262 Cr | -₹104 Cr | -₹139 Cr | -₹94 Cr | ₹14 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹1048 Cr | ₹430 Cr | ₹260 Cr | ₹421 Cr | ₹456 Cr | ₹349 Cr | ₹211 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹844 Cr | ₹271 Cr | ₹140 Cr | ₹306 Cr | ₹333 Cr | ₹278 Cr | ₹166 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| -₹702 Cr | -₹147 Cr | -₹221 Cr | -₹376 Cr | -₹205 Cr | -₹196 Cr | -₹109 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| -₹40 Cr | -₹136 Cr | -₹77 Cr | ₹64 Cr | ₹181 Cr | -₹63 Cr | -₹48 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹103 Cr | -₹12 Cr | -₹158 Cr | -₹6 Cr | ₹308 Cr | ₹18 Cr | ₹9 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹172 Cr | ₹184 Cr | ₹343 Cr | ₹349 Cr | ₹41 Cr | ₹22 Cr | ₹14 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| -₹27 L | -₹41 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹275 Cr | ₹172 Cr | ₹184 Cr | ₹343 Cr | ₹349 Cr | ₹41 Cr | ₹22 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
Fundamental Ratios
Consolidated
Standalone
No results found
Anthem Biosciences Share Price
854.45+18.95 (+2.27%)
+21.53% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 2
Bearish signals: 5 out of 9 oscillators
RSI
52.17Neutral
STOCH %K
83.40Sell
MACD Level(12,26)
-11.57Sell
Ultimate Oscillator
60.17Buy
Aroon Oscillator
-58.00Sell
BOP
0.65Buy
CCI
23.53Neutral
Williams %R
-16.60Sell
Momentum
-15.70Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 8
Bearish signals: 1 out of 9 moving averages
EMA 9
835.23Buy
SMA 9
828.22Buy
EMA 21
843.44Buy
SMA 21
842.76Buy
EMA 50
854.19Buy
SMA 50
880.44Sell
EMA 200
802.01Buy
SMA 200
768.55Buy
WMA 20
833.04Buy
Pivot
Pivot
Classic
Resistance 5
917.77
Resistance 4
896.87
Resistance 3
875.97
Resistance 2
855.07
Resistance 1
845.28
Pivot
834.17
Support 1
824.38
Support 2
813.27
Support 3
792.37
Support 4
771.47
Support 5
750.57
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Anthem Biosciences Share Price
854.45+18.95 (+2.27%)
+21.53% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jul 2025 |
|---|---|---|---|---|---|
| 71.40% | 71.42% | 74.68% | 74.69% | 74.69% | 74.69% |
| 3.79% | 2.57% | 1.28% | 1.37% | 1.66% | 1.50% |
| 2.85% | 2.33% | 1.43% | 0.71% | 0.53% | 1.38% |
| 9.25% | 11.15% | 10.12% | 6.89% | 6.68% | 2.21% |
| 12.71% | 12.53% | 12.49% | 16.34% | 16.44% | 20.22% |
Bulk & block deals
Name
Portsmouth Technologies Llc
Integrated Core Strategies Asia Pte Ltd
Icici Prudential Life Insurance Company Limited
Aruna Ganesh
360 One Mutual Fund
Kotak Mahindra Life Insurance Company Limited
Bajaj Life Insurance Limited
Canara Robeco Mutual Fund
Edelweiss Mutual Fund
Ghisallo Master Fund Lp
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 09 Oct 2026 | Sell | 249.90 Cr | ₹833 | 30 L | Bulk | 0.532675 | BSE |
| 18 Jun 2026 | Purchase | 14.90 L | ₹744.80 | 2 K | Block | 0.000355 | NSE |
| 18 Jun 2026 | Purchase | 90 Cr | ₹744.80 | 12.08 L | Block | 0.214558 | NSE |
| 18 Jun 2026 | Sell | 1,274.70 Cr | ₹744.80 | 1.71 Cr | Bulk | 3.038841 | NSE |
| 18 Jun 2026 | Purchase | 25 Cr | ₹744.80 | 3.36 L | Block | 0.059599 | NSE |
| 18 Jun 2026 | Purchase | 8 Cr | ₹744.80 | 1.07 L | Block | 0.01908 | NSE |
| 18 Jun 2026 | Purchase | 90 Cr | ₹744.80 | 12.08 L | Block | 0.214558 | NSE |
| 18 Jun 2026 | Purchase | 40 Cr | ₹744.80 | 5.37 L | Block | 0.095359 | NSE |
| 18 Jun 2026 | Purchase | 25 Cr | ₹744.80 | 3.36 L | Block | 0.059599 | NSE |
| 18 Jun 2026 | Purchase | 25 Cr | ₹744.80 | 3.36 L | Block | 0.059599 | NSE |
Insider trading & SAST
Client name
Viridity Tone Llp
Aruna Ganesh
Krithika Ganesh
Viridity Tone Llp
Aruna Ganesh
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21 Sep 2026 | Designated Person | Disposal | 0.159803 | 0.02 | 82.67 Cr | ₹918.60 | 9 L | 18 Sep 2026 | Market Sale | 1,00,000 | Insider Trading | — | Equity |
| 16 Jul 2026 | Promoter | Disposal | 3.05 | — | 0 | — | 1.71 Cr | 18 Jun 2026 | Market | — | SAST | 29(2) | — |
| 12 Mar 2026 | Promoter Group | Disposal | 1.523427 | 0 | 0 | — | 85.57 L | 09 Mar 2026 | Gift | 0 | Insider Trading | — | Equity Shares |
| 12 Mar 2026 | Designated Person | Disposal | 3.616395 | 0.18 | 1,255.25 Cr | ₹617.93 | 2.03 Cr | 09 Mar 2026 | Market Sale | 10,00,000 | Insider Trading | — | Equity Shares |
| 12 Mar 2026 | Promoter Group | Acquisition | 1.523427 | 3.05 | 0 | — | 85.57 L | 09 Mar 2026 | Gift | 1,71,14,604 | Insider Trading | — | Equity Shares |
Anthem Biosciences Share Price
854.45+18.95 (+2.27%)
+21.53% past 1 Year
Anthem Biosciences is an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing with integrated New Chemical Entity
Corporate Actions
Date
Type
Details
Company details
Anthem Biosciences Share Price
854.45+18.95 (+2.27%)
+21.53% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Anthem Biosciences Share Price
854.45+18.95 (+2.27%)
+21.53% past 1 Year
News
Anthem Biosciences Reports Stronger Second Quarter EBITDA And Margin
Equity
ANTHEM
Anthem Biosciences Reports Year On Year Growth In Second Quarter Net Profit
Equity
ANTHEM
Anthem Biosciences Reports Higher Second Quarter Revenue Growth
Equity
ANTHEM
Anthem Biosciences Portsmouth Technologies Sells Shares In BSE Block Trade
Equity
ANTHEM
Jefferies initiates Buy on Anthem Biosciences with Rs 1,050 target
Equity
ANTHEM
Anthem Biosciences sees Rs 118.42 crore NSE block trade at discount
Equity
ANTHEM
Large Anthem Biosciences BSE block trade signals institutional interest and liquidity
Equity
ANTHEM
Anthem Biosciences management reiterates confidence in regaining mid-teens growth trajectory
Equity
ANTHEM
Anthem Biosciences Q1 EBITDA declines year-on-year with margin contraction
Equity
ANTHEM
Anthem Biosciences reports Q1 revenue of Rs 384 crore versus Rs 538 crore year on year
Equity
ANTHEM
Anthem Biosciences Q1 net profit falls to Rs 102 crore versus last year
Equity
ANTHEM
Anthem Biosciences informs about newspaper publication
Equity
ANTHEM
Anthem Biosciences posted stronger Q4 EBITDA and improved operating margin YoY
Equity
ANTHEM
Anthem Biosciences reported strong Q4 results with robust profit growth
Equity
ANTHEM
Anthem Biosciences reports Profit after tax of 211.66 Crores, in the March 2026 quarter
Equity
ANTHEM
Citigroup initiates Buy on Anthem Biosciences with Rs 870 target, highlights CRDMO growth.
Equity
ANTHEM
Anthem Biosciences - Quaterly Results
Equity
ANTHEM
Anthem Biosciences reports Profit after tax of 112.13 Crores, in the December 2025 quarter
Equity
ANTHEM
Anthem Biosciences Q3 EBITDA Slightly Down YoY but Margin Expands to 37.15%.
Equity
ANTHEM
Anthem Biosciences Reports Q3 Revenue of Rs 420 Crores, Down from Rs 500 Crores YoY.
Equity
ANTHEM